A Study of MHB042C in Patients With Advanced Solid Tumors

NCT07192107 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG: MHB042C for Injection

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd